View in EDS PDF Full Text

Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor.

Saved in:
Bibliographic Details
Title: Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor.
Authors: Helman E; Guardant Health Inc, Redwood City, CA. Electronic address: ehelman@guardanthealth.com., Nguyen M; Clovis Oncology Inc, Boulder, CO., Karlovich CA; Frederick National Laboratory for Cancer Research, Frederick, MD., Despain D; Clovis Oncology Inc, Boulder, CO., Choquette AK; Virginia Cancer Specialists Research Institute, Fairfax, VA., Spira AI; Virginia Cancer Specialists Research Institute, Fairfax, VA., Yu HA; Memorial Sloan Kettering Cancer Center, New York, NY., Camidge DR; University of Colorado, Aurora, CO., Harding TC; Clovis Oncology Inc, Boulder, CO., Lanman RB; Guardant Health Inc, Redwood City, CA., Simmons AD; Clovis Oncology Inc, Boulder, CO.
Source: Clinical lung cancer [Clin Lung Cancer] 2018 Nov; Vol. 19 (6), pp. 518-530.e7. Date of Electronic Publication: 2018 Aug 07.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30279111
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Helman+E%22">Helman E</searchLink>; Guardant Health Inc, Redwood City, CA. Electronic address: ehelman@guardanthealth.com.<br /><searchLink fieldCode="AU" term="%22Nguyen+M%22">Nguyen M</searchLink>; Clovis Oncology Inc, Boulder, CO.<br /><searchLink fieldCode="AU" term="%22Karlovich+CA%22">Karlovich CA</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, MD.<br /><searchLink fieldCode="AU" term="%22Despain+D%22">Despain D</searchLink>; Clovis Oncology Inc, Boulder, CO.<br /><searchLink fieldCode="AU" term="%22Choquette+AK%22">Choquette AK</searchLink>; Virginia Cancer Specialists Research Institute, Fairfax, VA.<br /><searchLink fieldCode="AU" term="%22Spira+AI%22">Spira AI</searchLink>; Virginia Cancer Specialists Research Institute, Fairfax, VA.<br /><searchLink fieldCode="AU" term="%22Yu+HA%22">Yu HA</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Camidge+DR%22">Camidge DR</searchLink>; University of Colorado, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Harding+TC%22">Harding TC</searchLink>; Clovis Oncology Inc, Boulder, CO.<br /><searchLink fieldCode="AU" term="%22Lanman+RB%22">Lanman RB</searchLink>; Guardant Health Inc, Redwood City, CA.<br /><searchLink fieldCode="AU" term="%22Simmons+AD%22">Simmons AD</searchLink>; Clovis Oncology Inc, Boulder, CO.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100893225%22">Clinical lung cancer</searchLink> [Clin Lung Cancer] 2018 Nov; Vol. 19 (6), pp. 518-530.e7. <i>Date of Electronic Publication: </i>2018 Aug 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893225 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0690 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215257304%22">15257304 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30279111
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cllc.2018.07.008
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 518
    Titles:
      – TitleFull: Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Helman E
      – PersonEntity:
          Name:
            NameFull: Nguyen M
      – PersonEntity:
          Name:
            NameFull: Karlovich CA
      – PersonEntity:
          Name:
            NameFull: Despain D
      – PersonEntity:
          Name:
            NameFull: Choquette AK
      – PersonEntity:
          Name:
            NameFull: Spira AI
      – PersonEntity:
          Name:
            NameFull: Yu HA
      – PersonEntity:
          Name:
            NameFull: Camidge DR
      – PersonEntity:
          Name:
            NameFull: Harding TC
      – PersonEntity:
          Name:
            NameFull: Lanman RB
      – PersonEntity:
          Name:
            NameFull: Simmons AD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2018 Nov
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0690
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical lung cancer
              Type: main
ResultId 1